# A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome

> **NCT07675746** · EARLY_PHASE1 · RECRUITING · sponsor: **Second Affiliated Hospital of Guangzhou Medical University** · enrollment: 8 (estimated)

## Conditions studied

- Dravet Syndrome (DS)

## Interventions

- **DRUG:** RC001 injection-Dose Escalation Cohort
- **DRUG:** RC001 injection-Fixed Dose Cohort

## Key facts

- **NCT ID:** NCT07675746
- **Lead sponsor:** Second Affiliated Hospital of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-22
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2026-06-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07675746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07675746, "A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07675746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*